Anthrax vaccine - Emergent BioSolutions
Alternative Names: Oral anthrax vaccine - Emergent BioSolutionsLatest Information Update: 14 Aug 2009
At a glance
- Originator Emergent BioSolutions
- Class Anthrax vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anthrax
Most Recent Events
- 04 Sep 2006 No development reported - Preclinical for Anthrax in United Kingdom (PO)
- 27 Jun 2005 Microscience has been acquired by Emergent BioSolutions
- 05 Aug 2003 Preclinical trials in Anthrax in United Kingdom (PO)